Cited by

• Primary renal tumours in cats: 19 cases (1992-1998).

  Henry CJ, Turnquist SE, Smith A, Graham JC, Thamm DH, O'Brien M, Clifford CA. Henry CJ, et al. J Feline Med Surg. 1999 Sep;1(3):165-70. doi: 10.1016/S1098-612X(99)90205-X. J Feline Med Surg. 1999. PMID: 11919031 Free PMC article.
• Pathology and toxicology of beluga whales from the St. Lawrence Estuary, Quebec, Canada. Past, present and future.

  Martineau D, De Guise S, Fournier M, Shugart L, Girard C, Lagacé A, Béland P. Martineau D, et al. Sci Total Environ. 1994 Sep 16;154(2-3):201-15. doi: 10.1016/0048-9697(94)90088-4. Sci Total Environ. 1994. PMID: 7973607 Free PMC article. Review.
• Estimating canine cancer incidence: findings from a population-based tumour registry in northwestern Italy.

  Baioni E, Scanziani E, Vincenti MC, Leschiera M, Bozzetta E, Pezzolato M, Desiato R, Bertolini S, Maurella C, Ru G. Baioni E, et al. BMC Vet Res. 2017 Jun 28;13(1):203. doi: 10.1186/s12917-017-1126-0. BMC Vet Res. 2017. PMID: 28659149 Free PMC article.
• Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas.

  Zakimi N, Mazcko CN, Toedebusch C, Tawa G, Woolard K, LeBlanc AK, Dickinson PJ, Raleigh DR. Zakimi N, et al. Acta Neuropathol. 2024 Feb 20;147(1):43. doi: 10.1007/s00401-024-02693-2. Acta Neuropathol. 2024. PMID: 38376604 Free PMC article. No abstract available.
• The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas.

  Chambers MR, Bentley RT, Crossman DK, Foote JB, Koehler JW, Markert JM, Omar NB, Platt SR, Self DM, Shores A, Sorjonen DC, Waters AM, Yanke AB, Gillespie GY. Chambers MR, et al. Front Surg. 2020 Aug 28;7:59. doi: 10.3389/fsurg.2020.00059. eCollection 2020. Front Surg. 2020. PMID: 33005623 Free PMC article.